Document is current

Any future updates will be listed below

878 BET inhibition sensitizes immunologically-cold Rb-deficient prostate cancer to immune checkpoint blockade via DNA damage-induced STING/NF-κB/type I IFN signaling

Crossref DOI link: https://doi.org/10.1136/jitc-2022-SITC2022.0878

Published Online: 2022-11-07

Published Print: 2022-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark